US to Phase Out HIV/AIDS Funding for South Africa Amid Policy Disputes

The United States government intends to phase out its funding for HIV/AIDS programs in South Africa, a move that signals a significant shift in one of the world's largest HIV response partnerships. The decision, affecting support through the President’s Emergency Plan for AIDS Relief (PEPFAR), stems from policy disagreements and a deterioration in diplomatic ties between Washington and Pretoria.

A U.S. State Department official indicated that a "phased drawdown" of PEPFAR funding is imminent, citing South Africa's failure to meet policy requests made by the Donald Trump administration. The official argued that South Africa, as a middle-income nation, should be capable of financing its own health programs, framing the withdrawal as a step towards promoting self-reliance.

This announcement raises serious concerns given South Africa's status as the country with the highest number of people living with HIV globally, with over eight million residents affected. PEPFAR has been a critical component of the nation's HIV response for years, contributing approximately $400 million annually, though recent disruptions under the Trump administration had already impacted funding. South African authorities noted that while PEPFAR supports various programs, the procurement of essential antiretroviral medicines is primarily funded by the government.

The funding cut occurs against a backdrop of worsening relations between the two nations. Tensions have escalated since President Trump took office, with accusations of discriminatory policies against the white Afrikaner minority and criticism of South Africa's foreign policy stances, including its legal case against Israel at the International Court of Justice and its ties with Iran. The South African government has refuted these allegations, asserting that its Black Economic Empowerment policies aim to rectify historical inequalities without racial discrimination.

“

phased drawdown